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ABSTRACT 
The Effect of Gluten on Puberty Onset and  
Glycemic Response in Female Rats 
by 
Bethaney McLaughlin 
 
John C. Young, PhD, Examination Committee Chair 
Professor, Kinesiology and Nutrition Sciences  
University of Nevada, Las Vegas 
 
Introduction:	  While individuals with gluten sensitivities are instructed to follow a strict 
gluten-free diet, misinformed concerns over the consumption of gluten products has led 
to a rise in gluten avoidance diets, without a diagnosis of celiac disease.  Gluten-free 
products, and therefore the diet as a whole, have been found to have twice as much fat, 
reduced carbohydrates and fiber, and approximately one-third less protein (Miranda 
2014). Research on the effects of gluten-free diets on adolescent development is 
lacking. With recorded nutrient deficiencies in those that abstain from gluten, 
detrimental effects could be seen in adolescents who are put on non-prescribed gluten-
free diets. Body mass is one factor in puberty onset, and may occur earlier in individuals 
consuming a gluten-free diet, from lower quality ingredients used in gluten-free 
products.   
Purpose: To evaluate the effects of gluten on weight gain, body composition, glycemic 
response, and puberty onset in newly weaned female rats, hypothesizing that gluten 
restriction causes a faster increase in body fat, triggering an earlier onset of puberty. 
iv	  
Also, that gluten-restriction causes a higher increase in blood glucose than gluten-
containing food. 
Methods: Sprague-Dawley female weaned rats (n=20), age 23 days, were randomly 
separated into two groups, and fed either a gluten-free chow or a normal chow diet. 
Animals were housed separately at the UNLV LACF in a 12-hour light/dark cycle room; 
water was provided ad libitum. Food intake, body weight and blood glucose were 
recorded daily for two weeks. Blood was collected from a tail clip, and glucose was 
measured using a Bayer Contour glucose meter and test strips. Rats were checked 
daily for vaginal opening starting on the 25th day of life. After vaginal opening was 
confirmed, rats were euthanized and body composition was measured by a DXA scan.  
Results: Vaginal opening in the gluten-free group occurred earlier than in the control 
group (30 ± 2 vs 31 ± 2 days for gluten-free vs control respectively, p=0.01).  Percent 
body fat was increased in the gluten-free group compared with controls (13.8 ± 0.39 vs 
10.4 ± 0.72, p=0.015), however, weight gain (86 ± 2 vs 84 ± 3 g), food intake (236 ± 30 
vs 215 ± 24 g), and daily blood glucose (83 - 86 mg/dL vs 80 mg/dL - 85 mg/dL for 
gluten-free and control respectively) were not significantly different between the two 
groups. 
Conclusion: Vaginal opening, and hence onset of puberty, occurred sooner in rats fed 
the gluten-free diet.  Percent body fat was higher in the gluten-free group, consistent 
with the suggestion that increased body fat plays a role in the decreasing age of 
menarche in adolescent females.  These results reinforce the importance of diet and 
how it can affect growth and maturation. 
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CHAPTER 1 
INTRODUCTION 
 
 Adolescent years are the most important for consuming appropriate nutrient 
quantity. While breast milk and colostrum help transition the infant into a state of enteral 
nutrition, by promoting a functioning gastrointestinal (GI) tract and development of 
enzymes, post-weaning, the intestinal lumen builds new structures and increases 
functionality. Restrictive diets during pregnancy and the first years of life can retard 
growth, including of the stomach and intestines. The majority of skeletal development 
also occurs before puberty, therefore making childhood nutrition vital. Diets limiting 
consumption of certain food items, such as the gluten-free diet (GFD), may have 
detrimental effects on growth and maturation. 
 Celiac disease is a genetically linked autoimmune disease characterized by the 
inability of an individual to digest gluten, a protein found in wheat, rye, and barley, 
possibly causing damage to the small intestine. Misinformed concerns over the 
consumption of gluten products causing such issues as obesity and Autism in children, 
has lead to a rise in gluten avoidance diets, not contributed to a celiac disease 
diagnosis. A survey found that the top three reasons parents implemented a gluten-free 
diet in their child without confirmed celiac disease was due to irritability or poor temper, 
diarrhea, and weight issues (Tanpowpong 2012).   
 Individuals with gluten sensitivities are instructed to follow a strict gluten-free diet. 
Gluten is the normal property that allows wheat flour to leaven, when it combines with 
yeast, allowing bread to rise. Removing gluten to make gluten-free (GF) food items 
causes a change in product volume, cell structure, and texture (Capriles 2014). Poor 
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mouth feel and flavor can lead to lower intake of quality foods in children who are picky 
eaters. Also, gluten-free products tend to vary in micronutrient composition due to less 
than optimal wheat replacements.  
 Gluten-free products have lower levels of fiber and micronutrients compared to 
items with gluten, since wheat replacements tend to be refined flours, and are generally 
not enriched or fortified (Capriles 2014). A study that looked at a three-day food recall 
and evaluated gluten-free nutritional differences between their gluten counterparts 
found that due to differences in processing, gluten-free products, and therefore the diet 
as a whole, have twice as much fat, reduced carbohydrates and fiber, and 
approximately one-third less protein (Miranda 2014).  
 Lower micronutrient intake, higher calories, and intake of less than optimal food 
items can lead to issues in growing children, especially those on non-prescribed gluten 
free diets. Research on the effects of gluten-free diets on adolescent development is 
lacking. With recorded nutrient deficiencies in those that abstain from gluten, 
detrimental effects could be seen in adolescents that are put on non-prescribed gluten-
free diets. The findings that body mass is connected with puberty onset may show 
earlier onset in individuals consuming a gluten-free diet, from the possible consumption 
of hypercaloric foods.   
Research Hypothesis 
 The research focused on answering the question: Does the restriction of gluten 
from the diet effect adolescent development and initiate puberty sooner than a diet 
containing gluten? 
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  Hypothesis 1: Gluten restriction causes a faster gain of body fat, signaling an 
earlier onset of puberty than a non-restricted diet. 
 Null hypothesis 1: Gluten restriction does not cause a faster increase in body fat 
than a non-restrictive diet, and has no effect on puberty onset. 
 Hypothesis 2: Gluten restriction causes a higher increase in blood glucose than 
gluten containing food. 
 Null hypothesis 2: Gluten restriction and gluten containing food will show no 
differences on blood glucose. 
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CHAPTER 2 
THEORETICAL AND EMPIRICAL REVIEWS 
   
 Based on early research in the 1960s by Marshall and Tanner who observed 
variations in the age and time between the stages of development in female girls, norms 
(known as the Tanner Stages 1-5) were created for the timing of puberty events that are 
still utilized in Pediatrics today. The first signs of puberty generally appear between 8 ½ 
and 13 years of age in most (95%) girls, with full maturation reached between ages 11.8 
and 18.9 years, and menarche around 13 years old (Marshall & Tanner 1969). Since 
their research was published, the timing of pubertal development has steadily 
decreased, showing girls maturing at a much earlier age. This change is due to the 
many factors that control the onset of puberty. Genetics, hormones, environmental 
influence, and even the prenatal environment of the womb and maternal nutrition during 
lactation, can all affect the age at which an adolescent initiates maturation.  
 A neuropeptide, Kisspeptin, has been identified as a necessity for successful 
puberty. Kisspeptin has been found to stimulate the release of Gonadotropin Releasing 
Hormone (GnRH), a major hormone released from the hypothalamus that influences the 
start of menses. Research has manipulated the genome to knockout the Kiss1 gene in 
mice, which is how it was identified as a marker for puberty onset control; without the 
gene, mice had impairment or complete loss of puberty and eventually developed 
hypogonadotropic hypogonadism (Takumi 2015). Using this information, Takumi et. al 
looked further at control of the gene and possible influences on it by maternal diet 
during lactation. Two groups of dams were used: one fed a high-fat chow (HFD), the 
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other a normal chow, following birth of pups to the day of weaning.  Looking at the 
differences in Kiss1 expression in the arcuate nucleus, the pups in the HFD group 
showed a significantly higher expression (305.80 ± 31.90) than the pups in the normal 
diet group (198.00 ± 18.15) (Takumi 2015). The higher expression of the Kiss1 gene 
lead to significantly earlier vaginal opening of the HFD group (30.86 ± 0.27) than the 
normal diet group (31.19 ± 0.37) (Takumi 2015).  
 Frisch et. al. studied the effects of high-fat diet on estrus in 42 weaned baby rats. 
In rats fed a high-fat diet (24.6% of total calories), estrus was found to occur at day 33.3 
of age compared to 37.4 in rats on a low-fat diet (5.0%) (Frisch 1975). This was due to a 
fast increase in body weight and overall body fat. It’s hypothesized that the typical high-
energy, high-fat American diet causes metabolic effects, which can alter the timing of 
puberty in adolescents. 
 Leptin, the hormone secreted by adipose tissue that controls satiety, has also 
been studied as a possible influence on puberty onset because of its receptor located 
on kisspeptin, and the relation between body fat and puberty onset.  Ahima et. al. 
studied the effects of daily injections of recombinant leptin on the onset of puberty in 
post-weaned baby mice, and found that those with injected leptin had an earlier vaginal 
opening, estrus, and cycling, compared to controls (1997). The leptin-injected mice 
however, did not differ in body weight gain compared to the mice that were injected with 
a saline solution (Ahima 1997). Takumi et. al. also injected baby rat pups with either 
leptin or a vehicle, from day 15 to day 21 of life (weaning age), and then explored 
differences in body weight and expression of Kiss1 neurons. Takumi found no 
significant differences in each test (2015). Takumi’s research though only examined the 
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Kiss1 expression on day of weaning, which has been shown to be the lowest time of 
expression in general. Expression of the gene tends to occur post-weaning, therefore, a 
study with leptin injections until puberty onset, like Ahima et. al, may have shown 
different results. 
 A formula created by D. Frances Edwards and R. Kay, after studying differences in 
time elapsed between weaning and vaginal opening in rats of varying litter sizes, stated 
that the weight at vaginal opening was influenced by litter effect of male and females 
reared together, time of vaginal opening, and weight at weaning:  
Wvo = aj + bWw + ctvo + residual (1985). 
Previous research manipulating litter size determined that rats in small litters, 
approximately 4, tend to have overweight phenotypes, while rats in large litters, 
approximately 20, tend to have lean phenotypes (Smith & Spencer 2012). Edwards and 
Kay recorded weight at weaning and vaginal opening, as well as time in days elapsed 
between the events in 81 female baby rats, and found that the mean weight at vaginal 
opening was higher for rats from small litters (106.5 ± 2.2 g) and smaller for rats in 
larger litter (98.8 ± 2.1 g) (1985). Also, time elapsed between the two events was 
significant; the smaller litter with higher body weight had vaginal opening approximately 
1.4 ± 0.3 days sooner than the larger litter (Edwards & Kay 1985). Smith & Spencer also 
evaluated litter size effect, and looked at its effect on puberty onset. 
 Smith & Spencer randomly redistributed baby rats between dams to create varying 
litters of small, control, and large size, with 4, 12, and 20 pups respectively (2012). Male 
pups in the larger litter, considered underfed because of competition during nursing, 
showed slower puberty onset than control and the small litter (Smith & Spencer 2012). 
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Female pups in the small litter, considered over-fed because of more availability to 
nurse, reached puberty faster than control (Smith & Spencer 2012). Though food intake 
was not recorded, after pups were weaned and given equal access to chow, differences 
in body weights were still observed. Thus, babies that were fed by guardians rather than 
allowed to feed themselves, may have higher than needed intakes and continue on this 
trend in later stages of life, possibly setting up the individual for unhealthy weight gain. 
 While high-energy, high-fat diets can lead to a faster increase in weight change 
and change timing of puberty, under-feeding can also have effects on development and 
maturation. In one study, three groups of female pregnant Wistar rats were used: one 
control, one induced early by intra-uterine growth retardation, and one that was 
manipulated as a food restricted litter, which was of larger size, n=18 (Engelbregt 2000). 
Intra-uterine growth retardation (IUGR) caused the pups to be born smaller than normal 
(minus two standard deviations of the mean of the weight of control pups), simulating 
birth size of larger litters (Engelbregt 2000).  After being offered a normal diet post-
weaning, rats were checked for vaginal opening and body weight gain, and showed that 
rats in the food-restricted larger litter had the slowest rate of weight gain (Engelbregt 
2000). Pre-maturely born rats were significantly delayed in puberty onset compared to 
control (37.4 ± 2.7 compared to 36.1 ± 1.5), though the food restricted rats showed no 
difference in day of vaginal opening (Engelbregt 2000). This leads to the hypothesis that 
weight isn’t the necessary factor for puberty onset, but body composition in relation to 
fat percentage, could have more control. Since rats in the food restricted group were the 
smallest, but did not show delay of vaginal opening, they could have caught-up in body 
fat gain post-weaning when they were given the same access to food as the other test 
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groups. The IUGR rats were stopped in womb from developing completing like the other 
rats, which could have changed the number of adipose tissue cells that each was born 
with, thus not allowing for higher amounts of fat to be retained and causing a lower 
weight gain as well as a delay in puberty. 
  Similar to under-feeding, exclusion diets, like the gluten-free diet, need to be 
researched for possible implications on development. Research is available for macro- 
and micro-nutrient differences between gluten-free products and their standard 
counterparts. Polito et. al. studied the growth, both height and weight, in 17 children with 
celiac disease, who had a history of being on a gluten-free diet. From a three-day 
dietary recalls, researchers found an excess in calories, animal protein, and lipid intake, 
as well as a deficit in complex carbohydrates and vegetable proteins (Polito 1992). The 
researchers associated these dietary issues with the less than optimal food choices the 
children were making: mostly meats, cheeses, chocolate, fried potatoes, etc., since the 
modified wheat products most likely didn’t appeal to the children’s taste (Polito 1992).  
 In addition to the micronutrient differences and macronutrient proportions in a 
product, the protein digestibility and amino acid content can affect nutritional value. 
Burns et. al examined the differences in weight change in post-weaned beagles and 
rats given diets varying in protein levels, from 0% to 20%. The researchers also looked 
at protein utilization, by measuring nitrogen balance, of three different protein sources: 
soy, casein, and wheat gluten (Burns 1982). Five total experiments were performed. In 
the first experiment, research showed that the dogs on higher levels of protein actually 
consumed more food than those on lower to no protein (Burns 1982). This could be 
because of higher amounts of fat and carbohydrates, satisfying the dogs sooner than 
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those on the protein rich diet. Wheat gluten promoted changes in growth the least out of 
the three sources, though overall food intake was less in the wheat gluten, thus 
research cannot be used to signify wheat gluten as a unnecessary protein for growth. 
 Blazina et. al examined the differences in bone mineral density and Body Mass 
Index (BMI) for age of 55 children and adolescents with a celiac diagnosis, who had 
been on a strict gluten-free diet for two years (2010). Adherence to the GFD was 
determined by absence of endomysium antibodies for the past two years, though it was 
not stated where this information was obtained. The researchers also concluded that 
most of their subjects who followed the GFD for more than two years “had normal 
pubertal development,” and that delayed pubertal development occurred in those with 
different heights, which influenced bone mineral density and puberty onset (Blazina 
2010).  Researchers did not identify what markers pubertal development represented, 
though only height and weight were measured, and no questions of menstruation or 
bodily development were discussed.    
 Low intake of calcium and vitamin D can affect a growing child’s skeletal growth. 
Blazina et. al. examined the differences in bone mineral density of children on a strict 
gluten-free diet compared to children on a not strict diet (2010). The researchers found 
that though individuals on a not strict diet can have lower bone mineral density because 
of lack of absorption, due to inflamed mucosa of the small intestine, individuals on a 
strict gluten-free diet also have lower bone mineral density due to lower intake of 
calcium and vitamin D. Calcium intake was only 85% of the recommended intake in the 
strict GFD group (Blazina 2010). Serum vitamin D levels were recorded and found to be 
significantly deficient, below 50 nmol/L, for all subjects from December to mid April, 
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when sun exposure is minimal (Blazina 2010). Low calcium and vitamin D not only put 
younger individuals at increased risk of fractures and bone plate developmental issues, 
but also increase their risk of developing osteoporosis.   
 Research has assessed the differences in glycemic response between standard 
foods and gluten-free versions, and also between different types of wheat alternative 
foods. One study tested postprandial glucose response of three different gluten-free 
pastas in non-celiac and celiac subjects. All individuals were fed a meal that included 50 
grams of carbohydrates, from rice flour, corn flour, or a mix of both. The pasta made 
with rice flour showed the greatest increase in blood glucose after consumption, 
compared with the corn flour pasta and the mix of rice and corn flour pasta (Bacchetti 
2014). Rice is digested more quickly, which is why it showed a higher effect on blood 
glucose. Celiac participants had a higher glycemic effect compared to the control group, 
which could be due to differences in A1C (blood test showing average blood glucose 
over past two to three months; percentage of hemoglobin coated with sugar), intestinal 
lumen, or even pancreatic function, since there is a strong association between celiac 
and Type 1 Diabetes.   
 Gluten-free products are also digested differently and have been found to have 
negative effects on metabolic responses. Various pastas and breads, regular and 
gluten-free, as well as quinoa, were submerged in pepsin and pancreatic α-amylase in a 
test tube to simulate digestion, and then evaluated by how much sugar was diffused 
(Berti 2004). In vitro results showed significant differences in the gluten-free bread 
versus the standard bread product, with higher observed effects on Area Under the 
Curves (AUC) of digested starch over 5 hours from the gluten-free product (4426 ± 656 
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mg min dl-1) than the standard bread (3914 ± 191 mg min dl-1) (Berti 2004). No 
differences were seen between the two types of pasta and the quinoa (Berti 2004). This 
research shows that there can be great differences even between gluten-free products 
themselves.  
  Berti et. al. also looked at the various food products in vivo and evaluated 
glucose, insulin, free fatty acids, and triglyceride blood level effects from 50 grams of 
carbohydrate of each item (2004). Sample size was small: seven in the “healthy” subject 
group, and six celiac participants. The AUC of glucose response was much higher in the 
celiac subjects (2261 ± 2473 mg min dl-1 for GF pasta) compared to the “healthy” 
subject (1127 ± 758 mg min dl-1 for GF pasta) (Berti 2004).  During processing, 
removing gluten from a wheat based product causes a structural change so that the 
starch is more accessible, and thus decreases the rate of starch availability, causing a 
larger increase in glycemic response (Berti 2004). It’s possible that the differences in GI 
integrity could contribute to the differences in glycemic response. Celiac disease is also 
associated with a higher incidence of type 1 diabetes, therefore making the glycemic 
response of gluten an important aspect for future research’s focus.  
 In relation to the increased trend of individual’s choosing a gluten-free diet due to 
lack of information, a recent study showed that individual’s claiming to be “gluten 
sensitive” could not correctly identify gluten-free food items from standard items with 
gluten. Researchers studied 35 individuals with self-diagnosed gluten sensitivities (non-
celiac gluten sensitivity) who were maintaining a gluten-free diet. During the experiment, 
subjects were given 10 bags of 10 grams of either gluten-containing flour or gluten-free 
flour inside, and were instructed to sprinkle the flour on top of meals like pasta and 
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soup, to use one bag each day for a 10-day challenge (Zanini 2015). The experiment 
was repeated so that each individual experienced each type of flour. Two weeks were 
given in between the experiments as a “washout period”  (Zanini 2015). Participants 
were asked to record a food log, and answer the question at the end of the experiment, 
“Do you think that gluten was in the sachets labeled A, or in those labeled B?” (Zanini 
2015). Out of the 35 subjects tested, six stated they experienced no symptoms during 
the entire experiment; 17 experienced symptoms with gluten-free flour and 12 with 
gluten flour (Zanini 2015). Zanini et. al. hypothesized that the individuals who 
experienced gastrointestinal issues with the gluten-free flour may have intolerances to 
other ingredients in these and gluten products, or may be sensitive to FODMAPs 
(Fermented Oligo- Di- Mono- saccharides And Polyols) which have been shown to 
trigger similar symptoms as celiac disease in persons’ with Irritable Bowel Syndrome 
(IBS) (2015). This study provides further evidence that individuals should not self-
prescribe gluten-restricted diets; a celiac diagnosis or instruction from a Physician or 
other qualified Registered Dietitian Nutritionist should be obtained before major changes 
be made, that could possibly lead to nutrient deficiencies.   
  “Female Puberty: A Comprehensive Guide for Clinicians” looks at the trending 
decrease of puberty onset in children from a positive evolutional standpoint stating that 
it’s related to the increased availability of proper nutrition, which has lead to improved 
status and earlier body weight gain (2014). Early onset of puberty however, has been 
linked to “obesity, adult-onset diabetes, breast cancer, disordered eating, and anxiety,” 
as well as increased adolescent risk-taking behavior, teenage sexual intercourse, 
pregnancy, and STD exposure (Smith & Spencer 2012).  
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 Using previous data collected on 60 Italian gluten-free products, Pellegrini et. al. 
expanded her research by comparing nutrition information to gluten-containing 
counterparts. Pellegrini et. al. found that “potassium, phosphorus, calcium, iron, zinc, 
and B vitamins of almost all types of GF bread and pasta” tested, showed lower levels 
than standard products (2015). Also, 46 out of the 60 products tested were considered 
high sodium containing items, having greater than 400-500 mg sodium per 100 g of 
food (Pellegrini 2015). The American Heart Association recommends limiting sodium to 
less than 1,500 mg per day; most Americans consume more than twice this amount. 
This shows that salt is used to make gluten-free foods more appealing to a society that 
is accustomed to salty tasting food items. Consuming higher sodium gluten-free 
products increases an individual’s blood pressure, thus putting strain on the heart. 
These factors not only have negative implications for an individual in a state of 
maturation, but also put an individual at a higher risk of cardiovascular disease, the 
number one killer in the United States.     
 Data on the effects of gluten restriction on development and puberty onset is 
lacking. Though research has not yet focused on the effect of gluten restriction on 
maturation, nutrient deficiencies created from these products and differences in 
macronutrient content can shed light on possible effects during childhood. Nutrient 
deficiencies caused by lower quality macronutrients and elimination of needed fortified 
vitamins and minerals from gluten-free products can lead to stunted bone growth, 
excessive weight gain, and decrease age of puberty onset, potentially leading to 
disease in an adolescent’s future. Focusing research on the effect of gluten restriction 
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on body weight change, vaginal opening, and blood glucose can provide parents with 
additional evidence-based material when deciding how to structure their child’s diet. 
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CHAPTER 3 
METHODOLOGY 
Materials 
 Twenty Sprague-Dawley female newly weaned rats, age 23 days, were obtained 
from Taconic Biosciences, Inc (Taconic Biosciences, Rensselaer, NY). Pups had similar 
starting weight. Original weight was recorded with an average of 59 ± 5 grams, upon 
receiving. 
General Conditions 
 Rats were randomly assigned into one of two groups (n= 10/group) and fed either 
a normal chow diet (control) or gluten-free chow (treatment) (initial weight = 58.9 ± 3.9 
vs. 58.4 ±5.9 for control and treatment respectively, p=0.39), both formulated by LabDiet 
(LabDiet, St. Louis, MO). LabDiet’s formula 5053 was used as the standard chow. 
Wheat products and wheat-byproducts are removed to create a formula free of gluten 
ingredients.  
  Animals were housed in the UNLV LACF in separate cages so that daily food 
intake could be recorded. Housing is set in a 12-hour light/dark cycle room; water was 
provided ad libitum.  
Study Design 
 The body weight of each rat was recorded between 3 pm and 5 pm each 
afternoon. Food that was not consumed from the previous days feeding was collected 
and weighed. Separate containers were used to weigh food to reduce possible cross-
contamination of gluten containing food into non-wheat food. 
 Blood glucose was recorded daily using a Bayer Contour glucose meter  
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(Ascensia Diabetes Care, Parsippany, NJ) and test strips. Blood was collected from a 
tail clip (0.5 mL from the tip of tail). The first drop of blood was discarded; the second 
drop collected on a test strip and analyzed.  
 Rats were checked daily for vaginal opening starting on day 25 of life, by 
restraining the rat in one hand, on its back, and observing the vaginal cavity. The 
opening could be visualized by sight; it is sealed closed until hormonal stimulation. After 
vaginal opening was confirmed, rats were euthanized and body composition was 
measured by a dual energy x-ray absorptiometry (DXA) scan with small animal software 
(Lunar Prodigy, General Electric).  
Statistical Analysis 
 Age at vaginal opening, glucose, weight gain, body fat, and food intake were 
analyzed. Values that were skewed due to technical or experimenter errors were 
excluded from data analysis. A one-tailed, independent t-test was used to analyze 
differences between the two groups for weight gain (grams), age at vaginal opening, 
and feed efficiency. Statistically significant effects were set at p<0.05.  
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CHAPTER 4 
RESULTS 
Sample Characteristics 
 Descriptive data for the animals is summarized in table 1. The total sample size 
was 20 rats (n=10). The age was controlled: 23 days old upon receiving. The mean 
starting weight for the control group was 58.9 ± 4 g; treatment group was 58.4 ± 6 g 
(p=0.39).  
 
Table 1. Descriptive statistics for animals randomly assigned to control/treatment group. 
Category	   Sample	  
(n)	  
Pre-­‐Treatment	  
Weight	  
Mean	  (grams)	  
Post-­‐Treatment	  
Weight	  
Mean	  
(grams)	  
Percent	  
Weight	  
Change	  
Total	  Weight	  
Gain	  Across	  
Time	  (grams)	  
Age	  at	  
Vaginal	  
Opening	  
	  (days)	  
Control	   10	   58.9	  (S.D.	  3.9)	   142.7	  (S.D.	  11.1)	   59%	   83.9	  	  (S.D.	  9.7)	   31	  (S.D.	  2)	  
Treatment	   10	   58.4	  (S.D.	  5.9)	   144.5	  (S.D.	  8.5)	   60%	   86.2	  	  (S.D.	  6.3)	   30	  (S.D.	  2)	  
 
 Post-treatment weight was 142.7 ± 11 g for the control, compared to 144.5 ± 8.5 g 
for the treatment group. The treatment group gained more weight across time (86.1 ± 6 
g or 60% of original weight) than the control group (83.8 ± 10 g or 59% of original 
weight), though the weight change was not significant (p=0.29). Figure 1 expresses the 
similarity in growth of each test group. 
 Age of vaginal opening differed significantly between the two groups. The control 
group (M= 31 ± 2 days) was significantly delayed (p=0.01) to reach this measured 
marker for puberty onset than the treatment group (M=30 ± 2).  
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Figure 1. Weight Gained Across Time 
 
 
 
 Percent body fat was determined by a DXA scan (Table 2).  Mean differences in 
percent body fat between the two groups are shown in Figure 2. Although Rat 19 was 
found to be a significant outlier (Q1 – (1.5xIQR)= 12.65-(1.5x1.975) = 10.35; rat 19= 
8.5% body fat), rats in the gluten-restricted group had a significantly higher percentage 
of body fat (M=13.4, SE= 0.39), than rats fed a standard diet (M= 10.4, SE = 0.72), (p = 
0.015).  
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PERCENT 
BODY FAT 
(CONTROL 
1-10) 
PERCENT 
BODY FAT 
(TREATMENT 
11-20) 
 
12.2 14 
 
10.8 14.1 
 
12.6 12.5 
 
10.1 15.9 
 
10.7 12.6 
 
8.8 13.9 
 
5.1 14.2 
 
11.5 12.8 
 
12.6 8.5 
 
9.3 15.6 
MEAN 10.4 13.4 
S.D. 2.3 2.1 
 
 
 
Blood Glucose and Food Intake 
 The mean of the initial blood glucose was 77 mg/dL for the control group, while the 
treatment group had a mean glucose of 73 mg/dL. Figure 3 displays the average blood 
glucose values, with standard error bars, between the two groups across the time of the 
experiment. The treatment group showed a quartile range between 83 mg/dL and 86 
mg/dL, while the control group had more fluctuation, ranging between 80 mg/dL and 85 
mg/dL. Although there were day-to day fluctuations in glucose, the daily differences in 
glucose between groups were not significant (Appendix I). 
Figure 2. Differences in Percent  
Body Fat 
Table 2. Percent Body Fat Results 
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Figure 3. Average Blood Glucose Across Time  
 
 
 Nutrition facts and ingredients for each food type are shown in appendix II. The 
gluten containing ingredients were eliminated from the standard chow, the feed used for 
the control group, to make the feed for the treatment group. Protein, carbohydrates, and 
fat were maintained at equal percentages and contributed to the same caloric 
breakdown (control: 3.43 kcal/g; treatment: 3.44 kcal/g). The total food consumed for 
the control group was M=215.4 ± 23.9 g, while the treatment group consumed 
M=235.7± 29.7 g. Total food consumption between the two groups across the time of 
the experiment was not significant (p=0.053). Food efficiency, weight gained per calorie 
consumed, was also not significant (p=0.137).   
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CHAPTER 5 
DISCUSSION 
 Gluten-free products were designed for individuals with celiac disease who could 
not physically digest the gluten protein. Individuals without a celiac diagnosis started 
eliminating gluten from their diets based on the mistaken assumption that gluten was an 
unhealthy protein, which caused stomach upset or weight gain. Since research on the 
effects of gluten restriction is minimal, following an unnecessary gluten-free diet may 
lead to physical problems, especially in developing adolescents.  
 Previous research studying the potential factors that influence puberty onset have 
looked at genetic, physiological, and environmental factors with limited data focusing on 
special diets, in particular the gluten-free diet (Takumi 2015; Engelbregt 2000; Ahima 
1997). When gluten was restricted from the diet of post-weaned female rats, total food 
consumption and overall weight gain was similar to rats fed a gluten product, but body 
fat was significantly higher: 13.8% in treatment compared to 10.4% in control (p < 0.05). 
Body fat, rather than weight, has been previously examined as an indicator for early 
onset of puberty (Engelbregt 2000), and the significantly higher body fat did lead to 
pups maturing faster.  
 In newly weaned rats fed a high-fat diet (24.6% of total calories), estrus was found 
to occur at day 33.3 of age compared to 37.4 in rats on a low-fat diet (5.0%) (Frisch 
1975), ostensibly due to a rapid increase in body weight and overall body fat.  Similarly, 
mean weight at vaginal opening was higher for rats from small litters (106.5 ± 2.2 g) 
than rats from larger litter (98.8 ± 2.1 g), and rats from the smaller litter with higher body 
weight had vaginal opening approximately 1.4 ± 0.3 days sooner than rats from the 
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larger litter (Edwards & Kay 1985).  Conversely, pre-maturely born rats were 
significantly smaller than normal and puberty onset was delayed compared to control 
animals (Engelbregt 2000). The rats fed the gluten-restricted diet had significantly 
earlier vaginal opening, used as a marker for puberty onset, compared to rats fed a 
standard chow. Vaginal opening in the treatment group occurred in 30 ± 2 days 
compared with 31 ± 2 days in the control group.  
 While differences in micronutrient content has been shown from replacing wheat 
with less quality ingredients, focuses on the elimination of the gluten-containing 
ingredients, maintaining nutrient quality, was unknown. When rat feed was produced to 
examine this difference, overall food intake, feed efficiency, and blood glucose were not 
significantly affected. The total food consumed for the control group was M=215.4 ± 
23.9 g, while the treatment group consumed M=235.7± 29.7 g, and was not significant 
(p=0.053) across the time of the experiment. Since calories were kept consistent per 
gram of food as well, feed efficiency could be calculated and properly compared. Even 
with the almost significant differences in food consumption, feed efficiency was not 
significant (p=0.137). This can suggest that the slight difference in ingredients in the 
feed, the elimination of wheat products, could be a contributing factor to the differences 
in overall body fat.  
 Micronutrient content is controlled in animal feed to meet daily recommendations, 
though food made for human consumption is not always fortified or enriched. Gluten-
free products have lower levels of fiber and micronutrients compared to items with 
gluten, since wheat replacements tend to be refined flours, and are generally not 
enriched or fortified (Capriles 2014). Due to differences in processing, gluten-free 
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products, and therefore the diet as a whole, have twice as much fat, reduced 
carbohydrates and fiber, and approximately one-third less protein (Miranda 2014). In the 
current study, body fat were significantly higher in rats fed food that had wheat 
ingredients eliminated, but maintained the same ratio of macronutrients and 
micronutrients. Differences in bone mineral density, nutrition related blood levels, 
growth rate, and overall weight could therefore be affected in individuals that consume 
gluten-free products that are not properly held to high standards to replace missing 
vitamins and minerals.   
 Obesity and overweight, particularly higher amounts of adipose tissue and 
abdominal obesity, are linked to higher precedence of developing diabetes and 
metabolic syndrome. Differences in the effect on blood glucose and area under the 
glucose tolerance test curve have been seen between gluten-free products and their 
counterparts, though research has mainly looked at gluten-free products in individuals 
with celiac disease (Berti 2004; Bacchetti 2014). When rats without a celiac diagnosis 
were fed gluten-free chow, their blood glucose levels were not significantly different than 
the control. The average blood glucose levels across time are displayed in Figure 3. 
The treatment group tended to average between 83 mg/dL and 86 mg/dL, while the 
control group had more fluctuation, averaging between 80 mg/dL and 85 mg/dL, 
however the daily differences were not significant. The blood glucose was recorded 
daily during the nocturnal state of the rats, which was meant to simulate a fasting state. 
Blood glucose tended to be in the normal range, 70-100 mg/dL, though some rats did 
have glucose levels out of range, which could have skewed averages. From an 
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endocrinology view, the treatment group had more favorable levels, since the spiking 
levels as seen in the control group might create a higher risk for developing diabetes.  
Limitations of the Study 
 Since the research was performed on animals, certain aspects of data collection 
could not be performed. The study looked at only a short time period of the life of the 
rat, though it has been correlated that 13.2 rat days is equivalent to 1 human year 
(Sengupta 2013). Further growth was still expected in the rats, since the average full-
grown female Sprague-Dawley rat weights between 250 to 300 grams (Sengupta 2013).  
 Initial body fat could not be obtained, since animals had to lay still in a particular 
way for proper measurement. Having both pre- and post-body fat measurements would 
have provided further details on growth in the animals. 
 Food was available at all times for the rats, which could have caused error in blood 
glucose collection. Rats tended to awaken when data collection was conducted and 
may have consumed food before blood sampling was performed. Though it typically 
takes 15 minutes for the digestive system to start to breakdown carbohydrates and 
glucose to enter the blood stream, data collection of all twenty rats sometimes took up 
to one hour. Controlling food intake to control for actual fasted states might show 
different results on blood glucose.  
Conclusion and Recommendations for Future Research 
 Though this research focused primarily on the exclusion of gluten, human food 
equivalents, since they are not enriched and fortified like the rat chow studied, have 
been found to vary in micronutrients as well as macronutrients, suggesting possible 
further issues. Future research might look into the specific mineral and vitamin 
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differences when eliminating gluten-containing products to see if other influences on 
puberty may exist. Also, research controlling feed during the entire development stage 
is also important to study, to see if differences in body fat corrected, or if the 
continuation of gluten restriction led to even higher gains of body fat. 
 The results of this study indicated a significant effect of gluten restriction on total 
body fat and puberty onset in weanling rats. Vaginal opening, and hence onset of 
puberty, occurred sooner in rats fed the gluten-free diet.  Percent body fat was higher in 
the gluten-free group, consistent with the suggestion that increased body fat plays a role 
in the decreasing age of menarche in adolescent females. Further studies, along with 
the results of this research, can help reinforce the importance of diet and its effects on 
growth and maturation. 
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APPENDIX I: RAW DATA 
 
 
GROUP 
TOTAL 
WEIGHT 
GAIN 
PERCEN
T 
WEIGHT 
CHANGE 
TOTAL 
FOOD 
CONSUMED 
(GRAMS) 
FOOD 
EFFICIENCY 
BODY 
FAT 
(%)  
DAY	  OF	  
LIFE	  OF	  
VAGINAL	  
OPENING	  
Control  	      	  
1 85.6 62%	   203 1.45 12.2 31	  
2 87.1 57%	   220.8 1.35 10.8 31	  
3 78.8 55%	   224.8 1.20 12.6 30	  
4 83.4 58%	   250.5 1.14 10.1 32	  
5 96.5 63%	   222.3 1.49 10.7 34	  
6 81.8 59%	   213.9 1.31 8.8 31	  
7 61 53%	   156.5 1.34 5.1 27	  
8 85.8 59%	   221.6 1.33 11.5 31	  
9 94.5 61%	   224.3 1.45 12.6 31	  
10 83.7 59%	   215.9 1.33 9.3 31	  
MEAN	   83.8	   59%	   215.36	   1.34	   10.3	   31	  
S.D.	   9.68	   0.03	   23.90	   0.11	   2.27	   1.73	  
	   	   	   	   	   	   	  
	   	   	   	   	   	   	  Treatment  	      	  
11 87.4 62%	   197.4 1.52 14 31	  
12 90.1 58%	   264.7 1.17 14.1 31	  
13 72.6 52%	   283.8 0.88 12.5 30	  
14 88.2 59%	   227 1.34 15.9 30	  
15 79.3 59%	   197.7 1.38 12.6 31	  
16 90.7 62%	   219.5 1.42 13.9 31	  
17 94.1 58%	   230.9 1.40 14.2 27	  
18 87.7 62%	   236.6 1.28 12.8 29	  
19 83.3 62%	   226.1 1.27 8.5 29	  
20 88.3 62%	   273.7 1.11 15.6 27	  
MEAN	   86.2	   60%	   235.7	   1.28	   13.4	   30	  
S.D.	   6.24	   0.03	   29.75	   0.19	   2.07	   1.58	  
p-­‐value	   0.2976	   0.1580	   0.0530	   0.1371	   0.0151	   0.0112	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WEIGHT (GRAMS) 
 
SUBJECT DAY 1 DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7 
1 53 57 64.5 73 74.5 85 87.9 
2 65.5 68.5 75 82.5 88 98 99.9 
3 63.5 69 75 83.5 88.5 98.5 102.3 
4 60.5 66 72 80 86 95.5 100.7 
5 55.5 63 67 75 82.5 90.7 97 
6 57.5 62 68 75 78.7 88.5 91.5 
7 55 60.5 66 74 73.5 82 84 
8 59.5 64.5 70 79 83 94.5 97.5 
9 61 66 73.5 81 86.7 97 101.5 
10 58 62.5 71 78.5 82.5 89.7 95.2 
11 54.5 60 66.5 72.5 79 87 93 
12 65 71 79 88 93 102 105.2 
13 66 71 76.5 82.5 88.5 95.5 99.5 
14 61 67 73 81 87 96.2 99.5 
15 56 60 64 71.5 78 84 89.2 
16 55 60.5 66 74 81 89 104.7 
17 67 72.5 79 85.5 92.5 102.1 105.5 
18 53 59.5 66 73.5 78 85.7 89.5 
19 51 57 63 69.5 75 83.7 88.5 
20 55 61.5 67.5 75.5 81 88 95.5 
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WEIGHT CONTINUED 
 
SUBJECT	   DAY	  8	   DAY	  9	   DAY	  10	   DAY	  11	   DAY	  12	   DAY	  13	   DAY	  14	  
1	   96.7	   100.7	   106.7	   115.5	   121	   126.7	   138.6	  
2	   109	   114.7	   122.4	   127.3	   132.5	   139.7	   152.6	  
3	   109.7	   116.2	   123	   131	   139	   140.8	   142.3	  
4	   108.5	   115	   120.5	   123.6	   133.5	   135.6	   143.9	  
5	   106.3	   110.2	   116.7	   124.4	   132.6	   140.9	   152	  
6	   96.5	   102.2	   108.5	   119	   124.4	   131.3	   139.3	  
7	   90	   94.5	   98.2	   110	   114.5	   113.8	   116	  
8	   107.7	   113.2	   118.3	   128.3	   133.2	   137.4	   145.3	  
9	   109.5	   116.5	   125.5	   131.2	   142	   144.5	   155.5	  
10	   100	   107.4	   114.5	   122.4	   130.5	   131.8	   141.7	  
11	   103	   107.7	   113.7	   122.5	   129.6	   135.8	   141.9	  
12	   114	   119.4	   127.7	   133.3	   138.2	   145.5	   155.1	  
13	   106	   111.5	   117.7	   126.5	   134.2	   135.3	   138.6	  
14	   109.2	   116.5	   121.2	   128.5	   135	   138.6	   149.2	  
15	   96.9	   101.5	   109.2	   114.4	   121.1	   127.1	   135.3	  
16	   101.4	   109.5	   117.5	   125.4	   131.8	   135.4	   145.7	  
17	   114.7	   109.2	   127.5	   134.8	   145.2	   151.2	   161.1	  
18	   98.6	   104.5	   112	   119.7	   123.6	   130.4	   140.7	  
19	   98.2	   101	   110	   115.7	   122.7	   129.6	   134.3	  
20	   104.3	   109.7	   115	   122.7	   126.6	   131.5	   143.3	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BLOOD GLUCOSE VALUES (MG/DL) 
 
SU
B
JE
C
T 
DAY  
1 
DAY  
2 
DAY  
3 
DAY  
4 
DAY  
5 
DAY  
6 
DAY  
7 
DAY  
8 
DAY  
9 
DAY  
10 
DAY  
11 
DAY  
12 
DAY  
13 
DAY  
14 
1 91 93 82 82 100 82 93 84 78 76 92 88 79 102 
2 71 81 82 82 87 81 73 97 85 74 77 84 86 73 
3 80 74 84 112 91 88 92 76 98 80 85 87 84 89 
4 76 100 76 85 82 87 91 99 100 77 79 75 87 84 
5 80 92 85 98 90 89 83 97 91 97 87 75 83 93 
6 59 75 85 84 92 65 82 82 77 70 74 92 69 90 
7 66 68 76 76 67 73 62 92 68 82 70 75 71 80 
8 82 72 84 76 84 83 71 84 94 80 80 86 80 81 
9 87 80 93 90 90 80 85 88 73 87 89 79 73 72 
10 82 80 72 89 69 73 78 66 78 90 83 84 83 81 
11 78 95 81 89 92 95 96 104 106 80 96 100 90 95 
12 68 80 82 90 89 85 82 81 92 87 86 85 86 85 
13 92 85 76 69 73 69 78 62 94 79 77 86 79 82 
14 69 89 80 92 87 93 83 95 73 78 79 86 81 81 
15 75 81 67 108 83 88 78 67 69 83 89 75 82 88 
16 67 80 98 69 98 84 112 89 90 92 79 79 81 84 
17 72 91 80 74 78 75 81 86 76 78 78 80 91 79 
18 51 72 82 84 77 89 72 88 74 74 76 73 76 97 
19 77 93 101 96 92 92 102 93 88 102 97 98 91 87 
20 78 83 79 95 85 92 78 88 87 84 85 67 82 86 
p-
value 0.13 0.17 0.40 0.44 0.48 0.06 0.13 0.41 0.45 0.26 0.08 0.46 0.10 0.27 
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APPENDIX II: NUTRITION INFORMATION FOR RAT FEED 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
w w w . l a b d i e t . c o m03/17/15 
Nutrients2
Protein, %  . . . . . . . . . . . . . .21.0
Arginine, % . . . . . . . . . . . . . . .1.28
Cystine, %  . . . . . . . . . . . . . . .0.36
Glycine, %  . . . . . . . . . . . . . . .0.96
Histidine, %  . . . . . . . . . . . . . .0.52
Isoleucine, % . . . . . . . . . . . . . .0.86
Leucine, %  . . . . . . . . . . . . . . .1.56
Lysine, %  . . . . . . . . . . . . . . . .1.17
Methionine, %  . . . . . . . . . . . .0.62
Phenylalanine, %  . . . . . . . . . . .0.91
Tyrosine, %  . . . . . . . . . . . . . . .0.59
Threonine, %  . . . . . . . . . . . . .0.78
Tryptophan, %  . . . . . . . . . . . .0.24
Valine, % . . . . . . . . . . . . . . . . .0.96
Serine, %  . . . . . . . . . . . . . . . .0.98
Aspartic Acid, %  . . . . . . . . . . .2.18
Glutamic Acid, %  . . . . . . . . . .4.16
Alanine, %  . . . . . . . . . . . . . . .1.19
Proline, %  . . . . . . . . . . . . . . . .1.31
Taurine, %  . . . . . . . . . . . . . . .0.03
Fat (ether extract), %  . . . . . .5.0
Fat (acid hydrolysis), %  . . . .6.3
Cholesterol, ppm  . . . . . . . . . . .142
Linoleic Acid, %  . . . . . . . . . . .2.14
Linolenic Acid, %  . . . . . . . . . .0.27
Arachidonic Acid, %  . . . . . . .<0.01
Omega-3 Fatty Acids, %  . . . . .0.44
Total Saturated Fatty Acids, %  .0.78
Total Monounsaturated
Fatty Acids, %  . . . . . . . . . . . . .0.97
Fiber (Crude), %  . . . . . . . . . .4.5
Neutral Detergent Fiber3, % . . .15.8
Acid Detergent Fiber4, % . . . . . .5.8
Nitrogen-Free Extract
(by difference), % . . . . . . . . . .53.5
Starch, %  . . . . . . . . . . . . . . . .28.6
Glucose, %  . . . . . . . . . . . . . . .0.19
Fructose, %  . . . . . . . . . . . . . . .0.24
Sucrose, %  . . . . . . . . . . . . . . .3.24
Lactose, % . . . . . . . . . . . . . . . .1.34
Total Digestible Nutrients,% . .75.1
Gross Energy, kcal/gm  . . . . .4.11
Physiological Fuel Value5, 
kcal/gm . . . . . . . . . . . . . . . . . .3.43
Metabolizable Energy,
kcal/gm . . . . . . . . . . . . . . . . . .3.04
Minerals
Ash, %  . . . . . . . . . . . . . . . . . .5.9
Calcium, %  . . . . . . . . . . . . . . .0.81
Phosphorus, %  . . . . . . . . . . . .0.65
Phosphorus (non-phytate), % . .0.34
Potassium, %  . . . . . . . . . . . . . .1.09
Magnesium, %  . . . . . . . . . . . .0.23
Sulfur, % . . . . . . . . . . . . . . . . .0.33
Sodium, %  . . . . . . . . . . . . . . .0.30
Chloride, %  . . . . . . . . . . . . . .0.52
Fluorine, ppm . . . . . . . . . . . . . .9.3
Iron, ppm  . . . . . . . . . . . . . . . .200
Zinc, ppm  . . . . . . . . . . . . . . . . .89
Manganese, ppm  . . . . . . . . . . . .84
Copper, ppm  . . . . . . . . . . . . . . .14
Cobalt, ppm  . . . . . . . . . . . . . .0.71
Iodine, ppm  . . . . . . . . . . . . . .0.97
Chromium (added), ppm . . . . .0.01
Selenium, ppm  . . . . . . . . . . . .0.37
Vitamins
Carotene, ppm  . . . . . . . . . . . . .1.5
Vitamin K,ppm  . . . . . . . . . . . .3.3
Thiamin Hydrochloride, ppm . . .17
Riboflavin, ppm  . . . . . . . . . . . .8.0
Niacin, ppm  . . . . . . . . . . . . . . .85
Pantothenic Acid, ppm . . . . . . . .17
Choline Chloride, ppm  . . . . .2000
Folic Acid, ppm  . . . . . . . . . . . .3.0
Pyridoxine, ppm  . . . . . . . . . . . .9.6
Biotin, ppm  . . . . . . . . . . . . . .0.30
B12, mcg/kg  . . . . . . . . . . . . . . . .51
Vitamin A, IU/gm  . . . . . . . . . . .15
Vitamin D3 (added), IU/gm . . . .2.3
Vitamin E, IU/kg  . . . . . . . . . . .99
Ascorbic Acid, mg/gm  . . . . . . . .__
Calories provided by:
Protein, %  . . . . . . . . . . . . . .24.496
Fat (ether extract), %  . . . . . .13.123
Carbohydrates, % . . . . . . . . .62.380
*Product Code
1. Formulation based on calculated
values from the latest ingredient
analysis information.  Since nutri-
ent composition of natural ingre-
dients varies and some nutrient
loss will occur due to manufac-
turing processes, analysis will
differ accordingly.
2. Nutrients expressed as percent of
ration except where otherwise
indicated. Moisture content is
assumed to be 10.0% for the
purpose of calculations.
3. NDF = approximately cellulose,
hemi-cellulose and lignin.
4. ADF = approximately cellulose
and lignin.
5. Physiological Fuel Value 
(kcal/gm) = Sum of decimal
fractions of protein, fat and carbo-
hydrate (use Nitrogen Free
Extract) x 4,9,4 kcal/gm respec-
tively.
C H E M I C A L  C O M P O S I T I O N 1
PicoLab® Rodent Diet 20 5053*
PicoLab® Rodent Diet 20 EXT IRR 5R53*
D E S C R I P T I O N
PicoLab® Rodent Diet 20 is a 20% protein diet formulated for
rat, hamster and mouse breeding colonies. This diet is a complete
life cycle diet formulated using managed formulation, delivering
Constant Nutrition®. This is paired with the selection of highest
quality ingredients to assure minimal inherent biological varia-
tion in long-term studies. Irradiation gives reliable microbial
control and eliminates the need for autoclaving. Irradiation treat-
ment and special 3-ply packaging provide virtually bacteria-free
dietary control. 
Features and Benefits
• Managed Formulation delivers Constant Nutrition®
• Precision processing and selection of highest quality ingredi-
ents assures Constant Nutrition® quality
• Formulated with 20% protein 
• High quality animal protein added to create a superior
balance of amino acids for optimum performance 
• Recommended for rat breeding colonies and mice not requir-
ing a higher energy diet 
• Irradiation gives reliable microbial control and eliminates the
need for autoclaving
Product Forms Available Catalog #
• 5053:  Oval pellet, (3/8"x5/8"x1") 0007688
• 5R53:  Extruded Particle 3002890-742
• Meal (ground pellets), special order 0006939
Other Versions Available Catalog #
• 5061 Pico-Vac® Lab Rodent Diet 0048961
G U A R A N T E E D  A N A L Y S I S
Crude protein not less than  . . . . . . . . . . . . . . . . . . .20.0%
Crude fat not less than  . . . . . . . . . . . . . . . . . . . . . . . .4.5%
Crude fiber not more than  . . . . . . . . . . . . . . . . . . . . .6.0%
Ash not more than  . . . . . . . . . . . . . . . . . . . . . . . . . . .7.0%
Moisture not more than  . . . . . . . . . . . . . . . . . . . . . .12.0%
I N G R E D I E N T S
Ground corn, dehulled soybean meal, wheat middlings, whole
wheat, fish meal, dried beet pulp, wheat germ, cane molasses,
brewers dried yeast, ground oats, dehydrated alfalfa meal, soybean
oil, whey, calcium carbonate, salt, DL-methionine, menadione
dimethylpyrimidinol bisulfite (source of vitamin K), choline
chloride, pyridoxine hydrochloride, cholecalciferol, vitamin A
acetate, dl-alpha tocopheryl acetate (form of vitamin E), biotin,
folic acid, thiamine mononitrate, vitamin B12 supplement,
nicotinic acid, riboflavin supplement, calcium pantothenate,
manganous oxide, zinc oxide, ferrous carbonate, copper sulfate,
zinc sulfate, calcium iodate, cobalt carbonate, sodium selenite.
F E E D I N G  D I R E C T I O N S
Feed ad libitum. Provide plenty of fresh clean water at all times.   
Rats- All rats will eat varying amounts of feed depending on
their genetic origin. Larger strains will eat up to 30 grams per
day. Smaller strains will eat up to 15 grams per day. Feeders in rat
cages should be designed to hold two to three days supply of
feed at one time.  
Mice-Adult mice will eat up to 5 grams of pelleted ration daily.
Some of the larger strains may eat as much as 8 grams per day
per animal. Feed should be available on a free choice basis in
wire feeders above the floor of the cage.  
Hamsters-Adults will eat up to 14 grams per day.
For information regarding shelf life please visit www.labdiet.com.
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Acid Detergent Fiber   , % 5.6
Arginine, % 1.24 Ash, % 5.6
Biotin, ppm 0.3
Calcium, % 0.80
Chloride, % 0.55
Choline Chloride, ppm 2,000
Cobalt, ppm 0.71
Copper, ppm 12
Fat (ether extract), % 5.1
Fiber (max), % 4.6
Folic Acid, ppm 3.0
Glycine, % 1.00
Histidine, % 0.51
Iodine, ppm 1.02
Iron, ppm 174
Isoleucine, % 1.04
Leucine, % 1.70
Lysine, % 1.23
Magnesium, % 0.20
Manganese, ppm 67
Methionine, % 0.70
Neutral Detergent Fiber  , % 13.9
Pantothenic Acid, ppm 17
Phenylalanine, % 0.96
Phosphorus (available), % 0.28
Phosphorus, % 0.55
Potassium, % 1.04
Protein, % 21.1
Pyridoxine, ppm 9.61
Riboflavin, ppm 8.1
Selenium, ppm 0.35
Sodium, % 0.30
Sulfur, % 0.35
Thiamin Hydrochloride, ppm 16
Threonine, % 0.81
Tryptophan, % 0.26
Tyrosine, % 0.64
Valine, % 1.06
Vitamin A, IU/g 15
Vitamin B-12, mcg/kg 51
Vitamin D-3 (added), IU/g 2.3
Vitamin E, IU/kg 99
Vitamin K, ppm 3.3
Zinc, ppm 78
Niacin, ppm 84
Carotene, ppm 1.6
Ascorbic Acid, ppm 0
Cystine, % 0.30
Minerals
Vitamins
LabDiet 5053 without Wheat, Low Gluten
10/5/2015
Serine, % 1.13
Aspartic Acid, % 2.63
Glutamic Acid, % 4.23
Alanine, % 1.36
Proline, % 1.42
Taurine, % 0.03
Fat (acid hydrolysis), % 6.1
Cholesterol, ppm 152
Linoleic Acid, % 2.28
Linolenic Acid, % 0.27
Arachidonic Acid, % 0.02
Omega-3 Fatty Acids, % 0.44
Total Saturated Fatty Acids, % 0.99
Total Monounsaturated 
Fatty Acids, % 1.09
Nitrogen-Free Extract 
(by difference), % 53.6
Starch, % 31.04
Glucose, % 0.27
Fructose, % 0.32
Sucrose, % 3.48
Lactose, % 1.34
Total Digestible Nutrients, % 74.5
Energy (kcal/g) 3.44
Fluorine, ppm 10.8
Chromium (added), ppm 0.74
N U T R I T I O N A L   P R O F I L E 1
2
3
4
Protein 24.5
Fat (ether extract) 13.2
Carbohydrates 62.3
1.  Formulation based on calculated values 
from the latest ingredient analysis 
information.  Since nutrient composition of 
natural ingredients varies and some nutrient 
loss will occur due to manufacturing 
processes, analysis will differ accordingly.  
Nutrients expressed as percent of ration on 
an As-Fed basis except where otherwise 
indicated.  Moisture content is assumed to be 
10.0% for the purpose of calculations.
2.  NDF = approximately cellulose, hemi-
cellulose and lignin.
3.  ADF = approximately cellulose and lignin.
4.  Energy (kcal/gm) - Sum of decimal 
fractions of protein, fat and carbohydrate x 
4,9,4 kcal/gm respectively.
D E S C R I P T I O N
Modified LabDiet® Laboratory 5053 Diet without 
wheat, low Gluten.
57DD
I N G R E D I E N T S
Ground Corn, Dehulled Soybean Meal, Ground 
Oats, Fish Meal, Dried Beet Pulp, Cane Molasses, 
Brewers Dried Yeast, Dehydrated Alfalfa Meal, 
Soybean Oil, Dried Whey, Calcium Carbonate, 
Salt, DL-Methionine, 
Mineral and Vitamin Premix (Menadione 
Dimethylpyrimidinol Bisulfite (Vitamin K), 
Pyridoxine Hydrochloride, Cholecalciferol (Vitamin 
D-3), Trace Mineral Px (Manganous Oxide, Zinc 
Oxide, Ferrous Carbonate, Copper Sulfate, Zinc 
Sulfate, Calcium Iodate, Calcium Carbonate, 
Cobalt Carbonate), Vitamin A Acetate, DL-Alpha 
Tocopheryl Acetate (Form of Vitamin E), Biotin, 
Thiamin Mononitrate, Folic Acid, Vitamin B-12, 
Nicotinic Acid, Calcium Pantothenate, Riboflavin), 
Choline Chloride
F E E D I N G   D I R E C T I O N S
Feed ad libitum.  Plenty of fresh, clean water 
should be available at all times.
w w w . t e s t d i e t .  c o m 
CAUTION: 
Perishable - store upon receipt.
For laboratory animal use only; not for human 
consumption.
Product Forms Available* Catalog #
*Other Forms Available On Request
%kcalFrom:
0.845
0.455
2.144
Polyunsaturated Fatty Acids, % 2.00
CAUTION:  Contains a drug or compound for investigational use 
only in laboratory research animals or in vitro.  Not for human use.
Storage conditions are particularly critical to TestDiet® products, 
due to the absence of antioxidants or preservative agents.  To 
provide maximum protection against possible changes during 
storage, store in a dry, cool location.  Storage under refrigeration (2° 
C) is recommended.  Maximum shelf life is six months.  (If long term 
studies are involved, storing the diet at -20˚ C or colder may prolong 
shelf life.)  Be certain to keep in air tight containers.
1817142-2091/2" Pellet
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APPENDIX III: PROTOCOL FOR ANIMAL CARE AND USE 
 
 
- 1 - Generated on IRBNet
  
UNLV IACUC
Approved
 
DATE: July 21, 2015
  
TO: John Young, Ph.D.
FROM: UNLV IACUC
  
PROJECT TITLE: [758782-3] Effect of Gluten on Puberty Onset and Glycemic Response
REFERENCE #:  
SUBMISSION TYPE: Revision
  
ACTION: APPROVED
DECISION DATE: July 21, 2015
EXPIRATION DATE: July 20, 2018
 
Thank you for your submission of Revision materials for this research project. The UNLV IACUC has
APPROVED your submission. All research must be conducted in accordance with this approved
submission.
Please note that any revision to previously approved materials must be approved by this committee prior
to initiation. Please use the appropriate amendment form for this procedure.
Please report all NON-COMPLIANCE issues regarding this project to this committee.
Annual Review
This project requires annual review by this office. Please use the appropriate annual review form for this
procedure.
Renewals
All projects expire three years after the approval date. You must submit and obtain approval for a new
project prior to July 20, 2018 to avoid any lapse in approval.
If you have any questions, please contact Kevin Bergeron at (702) 895-5453 or kevin.bergeron@unlv.edu.
Please include your project title and reference number in all correspondence with this committee.
 
Office of Research Integrity - IACUC & IBC
4505 Maryland Parkway . Box 454022 . Las Vegas, Nevada 89154-4022
(702) 895-5453
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 Institutional Animal Care and Use Committee 
1/2015 
 
  
PROTOCOL FOR ANIMAL CARE AND USE 
 
1. PROJECT OR EXERCISE TITLE: Effect of Gluten on Puberty Onset and Glycemic Response      
 
2. PRINCIPAL INVESTIGATOR/COURSE DIRECTOR: 
NAME and TITLE: Dr. John Young (Professor and Advisory Committee Chair) 
DEPARTMENT: Kinesiology and Nutrition Sciences  
OFFICE PHONE: 702-895-4626  EMERGENCY PHONE: 
 
 
LAB CONTACT (TECHNICIAN) and PHONE NUMBER:  
LOCATION (BUILDING/LAB#):  
E-MAIL:john.young@unlv.edu FAX: 5-1500 
Does the PI have direct contact with the animals?   Yes    No   
 
3. LIST RESEARCHERS AND STAFF INVOLVED WITH ANY PROTOCOL PROCEDURES: 
Name Responsibility Office Phone Emergency Phone 
Bethaney McLaughlin Student  760-525-8379 
Dr. Laura Kruskall Co-PI 702-895-4985 702-274-0370 
Dr. James Navalta Data analysis 702-895-2344  
      Hit tab to add more rows to any of the tables in this form. Use the down arrow to move out of the table to the next field. 
 
4.   TRAINING FOR ALL PERSONNEL WORKING WITH ANIMALS ON THIS PROTOCOL: 
Name Role in this protocol 
(PI, co-PI, student, etc.) 
Experience working with species Training Received 
Dr. Jack Young PI 38 years 1991 UNLV 
Dr. Laura Kruskall Co-PI 13 years 2001 UNLV 
Bethaney McLaughlin Student 1 year 2015 UNLV 
 
5. PROTOCOL STATUS:   New/Renewal   Modification   
 
START DATE: July 2015 ANTICIPATED COMPLETION DATE (3 yr max): August 2015 
 
6. FUNDING SOURCE:          DEPARTMENT    OTHER INTRAMURAL SOURCE 
 EXTRAMURAL SOURCE   SPECIFY SOURCE:  
   IF FUNDED, GRANT NUMBER:  
 
7. CATEGORY OF ETHICAL CONCERN APPLICABLE TO THIS PROTOCOL (see Appendix A): C 
 
8.  JUSTIFICATION:  THIS SECTION IS REQUIRED FOR ANY PROJECT IN WHICH THERE IS A POTENTIAL 
      FOR PAIN, DISTRESS, OR DISCOMFORT THAT CANNOT BE ALLEVIATED.  EXAMPLES OF SUCH PROJECTS 
      INCLUDE INDUCED DISEASE STATES WHICH CAUSE SEVERE SYMPTOMS OR DEATH, SURGICAL  
      STUDIES RESULTING IN SEVERE POST-OPERATIVE DISCOMFORT OR LOSS OF FUNCTION, USE OF 
      SEVERE AND UNAVOIDABLE NOXIOUS STIMULI, AND SO FORTH.   
 
      a.  Will there be unrelieved pain or stress (defined as lasting for more than a moment, i.e. longer duration or more painful  
           than a needlestick)?    No    Yes 
 
      b.  If yes, provide justification and an indication of the number of animals, per year, that are going to experience 
           unrelieved pain or stress must be provided.  
 
 
      c.   Is death an end-point?    No    Yes   
 
      d.  If yes, explain why some earlier end-point data cannot be used instead (provide objective supporting data). 
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9. WILL THE PROJECT OR EXERCISE INVOLVE EXPOSURE OF ANIMALS OR ANIMAL HANDLERS TO: 
 
BIOHAZARDS?             NO      YES   IF YES, SPECIFY: 
 
 
RADIOISOTOPES?       NO      YES   IF YES, SPECIFY:  
CARCINOGENS?          NO      YES   IF YES, SPECIFY:  
TOXIC CHEMICALS?  NO      YES   IF YES, SPECIFY:  
 
    IF ANY ITEM ANSWERED YES, PLEASE COMPLETE AND ATTACH SUPPLEMENT FORM 1.  An approved   
Institutional Biosafety Committee protocol may be required. 
 
10. ITEMS WHICH APPLY TO THIS PROJECT: 
     
     Blood and/or tissue collection    Survival surgery                        
     Antibody production and collection  Non-survival surgery  
     Behavioral studies  Aseptic surgery  
     Prolonged physical restraint  Multiple surgeries on the same animal 
     Food or water deprivation  Alleviated pain 
     Environmental extremes  Unalleviated pain 
     Electrical stimuli  Anesthetics used 
     Induction of trauma  Single housing  
     Work to be done off campus                              Immobilizing agents without anesthesia  
     Field studies  
 
11. IS SURGERY INVOLVED IN THE PROPOSED PROJECT? 
       No   Yes   IF YES, ATTACH SUPPLEMENT 2 
 
12. ARE STRESSFUL OR PAINFUL PROCEDURES, OTHER THAN SURGERY, PART OF THIS PROJECT? 
       No   Yes  IF YES, ATTACH SUPPLEMENT FORM 3 
 
13. ARE PROLONGED (MORE THAN A FEW HOURS) PHYSICAL RESTRAINT PROCEDURES PART OF THIS         
      PROJECT? 
       No   Yes  IF YES, ATTACH SUPPLEMENT FORM 4 
 
14. WILL GENETICALLY ENGINEERED OR OTHER MUTANT ANIMALS BE PRODUCED OR MAINTAINED 
      THAT MAY BE EXPECTED TO DEVELOP CLINICAL SIGNS AS A RESULT OF THE MUTATION? 
       No   Yes  IF YES, ATTACH SUPPLEMENT FORM 5.  AN APPROVED INSTITUTIONAL BIOSAFETY    
      COMMITTEE PROTOCOL IS ALSO REQUIRED. 
 
15. WILL TISSUES, CELLS OR OTHER PRODUCTS DERIVED FROM ANIMALS BE SHARED OR A TISSUE BANK   
       ESTABLISHED FOR FUTURE SHARING WITH OTHER INVESTIGATORS DURING OR AFTER THE PROJECT?   
        No    Yes   
 
16. ARE BEHAVIORAL STUDIES INVOLVED IN THIS PROJECT?   Yes    No 
       Do any of the following procedures or conditions apply? 
 
      Food Reward                     
      Electrical Shock                                      Strength and duration:   
      Food Deprivation                                    Kcal/day provided:       
      Water Deprivation                                    ml/kg provided:           
 
     If a conditioning protocol applies, please explain the purpose.  
  
     Criteria for monitoring the condition of the animals during food and water deprivation: 
 
 
17. ARE THERE ANY EXCEPTIONS TO THE GUIDE (Guide for the Care and Use of Laboratory Animals, National Research 
Council)?  Yes    No 
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 If yes, describe the exceptions in detail including the scientific justification for the exception.  The most common 
exceptions include; single housing, lighting, food/water variations, cage changes, temperature, ventilation, or euthanasia 
method that differs from the guide.  
Single housing will be used to accurately measure food intake for each animal used. Research evaluating stress hormone 
levels and food intake of single-housed versus paired animals found no differences in stress hormone measures, 24-hour 
food intakes or body weight gain (Boggiano et. al. Physiology and Behavior, 95(1-2), 222-228). Food variations, standard 
gluten chow and gluten-free chow, will be used to see the effects of gluten exclusion on puberty and glycemic response. 
Both gluten and gluten-free chow will be obtained from Research Diets, who make their standard chow without gluten 
products, by using corn and casein. Numerous published research projects have used Research Diets chow, including a 
study looking at the effects of a gluten-free diet on intestinal microbiome (Marietta et.al PLoS ONE 8(11): e78687).  
 
 
18. ANIMAL CENSUS AND HOUSING - Use one line/species/pain category.  Repeat table rows as needed. 
  Common Species 
Name/Scientific Name Strain/Stock Breed Sex 
Starting 
Age/Weight Total # Requested 
Pain 
Category 
Rat / Rattus norvegicus Wistar/Sprague-
Dawley 
F 21 days; 
approx. 60 g 
20 C 
      
       
During the course of the study, list the source of the animals and the expected average daily census: 
Average Daily Census: 20 Source of the animals: Approved Vendor 
  
  
         
Will these animals be bred?  If so explain, please include numbers of animals bred and anticipated number of offspring.
NA 
 
19. LOCATION OF ANIMAL HOUSING AND USE AREAS: 
 
      ANIMAL HOUSING FACILITY: UNLV LACF 
      WILL ANIMALS BE REMOVED FROM THE HOUSING FACILITY FOR USE ELSEWHERE? 
        No     Yes IF YES, SPECIFY LOCATIONS: 
 
Procedures Building or Site Room 
Non surgical procedures or conditions   
Nonsurvival surgery   
Survival surgery   
Postsurgical/Postanesthesia/Postprocedural 
Recovery 
  
 
Maximum number of hours at one time the animals will be kept in the laboratory/surgery: 
 0-12 hrs   12-24 hrs   over 24 hrs  (Animals kept over 24hours require an establishment of an IACUC approved satellite 
facility.)  
 
20. ARE THERE ANY SPECIAL REQUIREMENTS FOR ANIMAL HOUSING, DIETS, RESTRAINT, OR PROCEDURES 
      FOR DISPOSAL?   Yes    No 
 
      IF NO, ANIMALS WILL BE MAINTAINED ACCORDING TO THE STANDARD OPERATING PROCEDURES.  IF  
      YES, PROVIDE (AN) EXPLANATION(S) FOR EACH PARAMETER INVOLVED (E.G., LIGHT:DARK CYCLES, 
      HUMIDITY, AMBIENT TEMPERATURE, CAGING BEDDING, DIETS, AND SO FORTH):  
Rats will be fed either a diet formulated with gluten or a gluten-free diet, both purchased from Research Diets INC. This 
is needed to determine effects of gluten on weight change, puberty onset, and blood glucose.   
 
21. INSTRUCTIONS FOR DISPOSITION OF SICK OR INJURED ANIMALS 
 
      Call Investigator     Veterinarian (or Designee) to Treat      Euthanize    
 
22. INSTRUCTIONS FOR DISPOSITION OF DEAD ANIMALS 
 
      Call Investigator       Veterinarian (or Designee) to Necropsy     Bag for Disposal  
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23. IF WILD OR EXOTIC SPECIES ARE TO BE USED:   
 
      a.  ARE SPECIAL PERMITS REQUIRED?    Yes    No 
           IF YES, ATTACH A COPY OF APPLICABLE PERMITS OR PERMIT APPLICATIONS 
 
      b.  WILL ANIMALS BE OBSERVED, MANIPULATED, OR TRAPPED IN THE WILD?   Yes   No 
      IF YES, AND THEY HAVE NOT ALREADY BEEN ADDRESSED, DESCRIBE THE FIELD PROCEDURE(S)   
      INCLUDING THE GEOGRAPHIC LOCATION(S) INVOLVED:
 
 
  24. ADMINISTRATION OF ANESTHETICS AND ANALGESICS.  
Species Drug Route Site/location Volume Dosage Frequency 
NA       
       
 
25. ADMINISTRATION OF EXOGENOUS SUBSTANCES 
Complete this section for all drugs, infectious agents, carcinogens, toxins, experimental compounds, etc. 
Species Drug/Substances Route Site/Location Volume Dosage Frequency 
NA       
       
All substances must be pharmaceutical grade. If non-pharmaceutical grade substances will be used, please list the substance 
and explain why a pharmaceutical grade cannot be used:   
 
Other Comments: 
 
 
26. ANTEMORTUM FLUID/TISSUE COLLECTION 
Species Type of Fluid 
or Tissue 
Volume or 
Mass 
Frequency of 
Collection 
Method or Route 
of Collection 
Anesthesia or 
Sedation Used? 
Rat Blood 2 drops (2µl) Daily Tail Vein No 
      
 
27. EUTHANASIA 
Species Method and 
Secondary Method  (if 
applicable) 
Drug (if applicable) Dose of Drug mg/kg 
(if applicable) 
Route 
Rat CO2 
 
 
  Inhalation 
Rat Bilateral 
pneumothorax 
 
Note: carcasses must 
be intact for DEXA 
scan, so opening chest 
cavity and severing 
heart will be done after 
the DEXA scan is 
completed 
   
 
28. LAY SUMMARY  
 
This summary may be forwarded to the Office of Public Affairs.  They may use it to describe your research to the media. 
The lay summary should be brief and readily understandable to the general public. Provide a summary of the project that 
explains the need for the research, what the project goals are, and how the use of animals will help reach the stated goals: 
Adolescent years are the most important for consuming appropriate nutrient quantity. Diets limiting consumption of 
certain food items, such as the gluten-free diet, may have detrimental effects on growth and maturation. Research 
evaluating nutrient differences between gluten-free products and traditional counterparts have found that gluten-free 
items tend to be higher in fat, have reduced fiber and carbohydrates, and possible differences in protein levels (Miranda 
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Plant Foods for Human Nutrition, 69(2), 182-187).  Nutrient consumption in individuals on a gluten-free diet has shown 
below recommended intake of B vitamins, vitamin D, zinc, calcium, fiber, iron, and magnesium, all essential nutrients for 
a developing child (Lamacchia Nutrients 2014(6), 575-590). The proposed research will evaluate the effects of gluten on 
weight change, glycemic response, and puberty onset in 21-day-old rats, hypothesizing that gluten restriction causes a 
faster increase in body weight, signaling the onset of puberty earlier than rats on a non-restricted diet. Glycemic response 
will also be determined to see if differences arise during a gluten-free diet. Rats tend to reach puberty within 6 weeks of 
birth, making them ideal subjects for this study. To determine overall changes in body composition and fat stores, a post-
mortem procedure will be utilized, therefore making it necessary to use animals in this study.   
 
 
29. EXPERIMENTAL SUMMARY   
 
      ALL 3 QUESTIONS MUST BE ANSWERED. 
 
     a.  What are the objectives or underlying hypotheses of the experiment?
The proposed research will evaluate the effects of gluten on weight change, body composition, glycemic response, and 
puberty onset in 21 day old rats, hypothesizing that gluten restriction causes a faster increase in body weight, signaling 
the onset of puberty earlier than rats on a non-restricted diet. 
 
     b.  What happens to the animals from start to finish (please give a detailed description of all procedures)?
In this experiment, 20 female weaned rats, age 21 days, with similar starting weight, approximately 60 grams, will be 
randomly separated into two groups and fed either a gluten-free chow or a normal chow diet. Animals will be housed in 
the UNLV LACF in separate cages so that daily food intake can be recorded. Rats will be in a controlled temperature 
setting, with 12 hours of light and 12 hours of dark. At approximately the same time each morning, body weight of each 
rat, as well as weight of remaining food from the previous nights’ feeding, will be recorded.  
Blood glucose will be measured daily, at the same time as animals are weighed, to see possible changes in glycemic 
response between the two groups. Blood will be collected by a tail clip (0.5 mm tip of tail). The first drop of blood will be 
discarded; the second drop will be collected on a test strip and be analyzed by a standard glucose meter.  To sample for 
blood glucose on successive days, we will attempt to collect blood from the previous tail clip by wetting and removing 
the scab.  A new tail clip will be done if the scab from the previous clip is sufficiently healed to prevent obtaining a drop 
of blood.  Starting on day 10 of the experiment, rats will be checked daily for vaginal opening at the same time as animals 
are weighed and blood glucose is measured. Upon the day of vaginal opening, rats will be euthanized to determine body 
composition.  After euthanization, via CO2 inhalation, animals will be transported to BHS 335 where body composition 
will be determined by dual energy x-ray absorptimerty (DEXA) with small animal software. Animal carcasses will be 
placed on an absorbent underpad separating the carcass from direct contact with the DEXA surface. Following DEXA 
scans, carcasses will be returned to LACF for disposal.  
            
c.  Why was this species or strain selected?
Rats were selected because the species tend to be a commonly used and convenient model. Since this experiment will 
look at puberty onset, rats grow and mature very quickly, and therefore can show results in a shorter period of time. 
Typically a day for a rat is equivalent to approximately 110 human days (Sengupta). Research began using rats to study 
reproductive physiology and puberty in the 1930s, and thus make a good model to use for this experiment.  
    
d.  How many animals will be used and how did you determine that this will be a sufficient number?
 
i.  Number of animals requested: 
Twenty; two groups of 10 animals each (10 standard chow and 10 gluten-free chow) 
 
ii.  How did you determine that this would be a sufficient number? (Choose at least one)  
 
                    Statistical power analysis (please describe) 
 
 
                    Similar published experiments (cite references) 
Group size in research looking at the effects of diet on growth in weanling rats ranges from 4-12 animals per treatment 
group.  Based on this research, we believe 20 rats (n=10 per group) is a sufficient number of animals to demonstrate a 
treatment effect in this study.   
 
Howe, EE and CL Dooley.  Effect of delayed supplementation of wheat gluten with lysine and threonine on its 
capacity to promote growth in the weanling rat.  J. Nutrition 81: 379-382, 1963 
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Mustin B, D Peace, and CH Anderson.  Food intake regulation in the weanling rat: self-selection of protein and 
energy.  J. Nutrition 104: 563-572, 1974 
 
 
Ashley, DVM and CH Anderson.  Food intake regulation in the weanling rat: effects of the most limiting 
essential amino acids of gluten, casein, and zein on the self-selection of protein and energy.  J. Nutrition 105: 
1405-1411, 1975 
Ashley, DVM and CH Anderson.  Correlation between the plasma tryptophan to neutral amino acid ratio and 
protein intake in the weanling rat.  J. Nutrition 105: 1412-1421, 1975 
 
Landmann, WA, CW Dill, and CR Young.  Nutritive value of globin-amino acid and complementary globin-
cereal mixtures.  J Nutrition 110: 2254-226, 1980 
 
Phillips, RD.  Estimators of body nitrogen in growing rats fed varying levels and qualities of protein.  J. 
Nutrition 110: 1441-1452, 1980 
 
Phillips, RD. Linear and nonlinear models for measuring protein nutritional quality.  J. Nutrition 111: 1058-
1066, 1981 
 
Burns RA, MH LeFaivre and JA Milner.  Effects of dietary protein quantity and quality on the growth of dogs 
and rats.  J. Nutrition 112: 1843-1853, 1982 
 
Finke, MD, GR DeFoliart, and NJ Benevenga.  Use of a four-parameter logistic model to evaluate the protein 
quality of mixtures of Mormon cricket meal and corn gluten meal in rats.  J. Nutrition 117: 1740-1750, 1987 
 
Sampson DA, SC Harrison, SD Clarke, and X Yan.  Dietaary protein quality alters ornithine decarboxylase 
activity but not vitamin B-6 nutritional status in rats.  J. Nutrition 125: 2199-2207, 1995 
 
 
                    Special consideration for difficult to obtain, rare, or endangered species, explain for clarification 
 
  
  
e. For 3-year renewals please describe what has been accomplished in the past 3 years and how this protocol differs from the 
previously approved protocol (for new protocols indicate N/A): 
N/A 
 
 
30. ASSURANCES (See Appendix B) 
            
I have searched the following sources for alternatives to animal model.  
 
Data Source 
Searched  
From (Yr) 
Searched  
To (Yr) 
Keywords used in the Search Date Search 
Performed 
PubMed 1995 2015 Gluten-free, puberty, non-celiac, 
development; gluten-free and 
blood glucose 
4/18/2015 
UNLV Library   Gluten-free, puberty, non-celiac, 
development; gluten-free and 
blood glucose 
4/18/2015 
Google Scholar 1995 2015 Gluten-free, puberty, non-celiac, 
development; gluten-free and 
blood glucose 
4/18/2015 
     
     
 
Alternatives refer to methods or approaches which result in refinement of procedures which lessen pain and/or distress; 
reduction in numbers of animals required; or replacement of animals with non-whole-animal systems or replacement of one 
animal species with another, particularly if the substituted species is non-mammalian or invertebrate.  
I have determined that the following alternatives are available. Described briefly if applicable: 
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This study involves diet modification during pre-puberty, to access possible implications on growth and maturation. 
Other possible models are larger mammalians (rhesus monkey) or humans, which would not be a reasonable alternative 
model.  
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Investigator Certifications  
 
By submitting and digitally signing this package in IRBNet, you agree to the following certifications: 
 
I understand that 'unnecessarily duplicative' research involving laboratory animals is not permitted by the federal animal welfare 
law and hereby provide assurance that the research proposed herein does not, to the best of my knowledge, unnecessarily 
duplicate research already reported in the public literature. 
 
I certify that the use of all animals involved in this project will be carried out according to the provisions of the Animal Welfare 
Act, PHS Policy, the principals of the 'NIH Guide for the Care and Use of Laboratory Animals', and the UNLV Policy Governing 
The Use of Animals in Research, Teaching and Testing.  I agree to notify the UNLV Institutional Animal Care and Use 
Committee (IACUC) of any substantive changes in the research use of the animals, including the number of animals, species 
used, or procedures performed. 
 
I understand that the University of Nevada, Las Vegas and its representatives on the IACUC have the authority to suspend any 
part of my research, should I not be in compliance at any time with USDA, PHS/NIH, or UNLV regulations for animal care and 
use. 
 
I certify that all personnel having direct animal contact, including the investigator, have or will have, prior to participating in 
this protocol, been trained in humane and scientifically acceptable procedures in animal handling, administration of 
anesthetics, analgesics, and euthanasia to be used in this project or are under the direct (in-lab) supervision of a trained 
individual; and that employees will be allowed adequate time to attend training sessions. 
 
I assure that all named individuals on this project have read and understood the procedures outlined in this protocol as 
approved by the IACUC. 
 
I certify that I will obtain approval from the IACUC before initiating any significant changes in this study. 
 
I certify that I will notify the IACUC regarding any unexpected study results that impact the animals. Any unanticipated 
pain or distress, morbidity or mortality will be reported to the attending veterinarian and the IACUC. 
 
I certify that the information provided in this application is accurate to the best of my knowledge. I also understand that should I 
use the project described in this application as a basis for a proposal for funding (either intramural or extramural), it is my 
responsibility to ensure that the description of animal use in such funding proposal is identical in principle to that contained in 
this protocol. 
 
I understand that the Department of Laboratory Animal Care Services is responsible for administering and assigning animal 
housing space within the central animal facilities. The Manager, LACF will make space assignments for the efficient utilization 
of space, which may result in investigators sharing animal housing space. I further realize that I must notify the Manager, LACF 
of animal housing needs in order to insure the availability of suitable space before animals are procured. 
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Appendix A 
 
CATEGORIES OF ETHICAL CONCERN FOR USE OF VERTEBRATE ANIMALS IN TEACHING AND RESEARCH 
PROGRAMS 
 
The USDA has established categories of invasiveness for animal research which must be addressed in the protocol.  The 
University reports to the USDA how many USDA animals are used each year in each category. 
 
CATEGORY B: Maintaining animals without experimentally manipulating them in any way.  Standard animal care and food, 
water, and shelter/enclosures are all that the animals experience.  Any bleeding, tail clips or other manipulations are not allowed. 
Some breeding colonies, conditioning periods as well as field studies with only observation and no animal contact would qualify 
for Category B. 
 
CATEGORY C:  Experiments or teaching exercises that involve no or minimal pain or distress to vertebrate animal species.  For 
Category C procedures no pain-relieving drugs or anesthetic drugs are utilized because animals experience, at most, no more than 
transient slight pain or distress. These manipulations might include minor blood sampling, injections with benign substances 
(NOT Freund's adjuvant), use of positive rewards for training, tail clips, ear tagging or punching, and euthanasia for tissue 
collection.  If any of these manipulations are done under anesthesia, this would then make them Category D. 
 
((Examples - Holding animals captive for experimental purposes; simple procedures such as observing feed selection preferences; 
injections of relatively harmless substances such as therapeutic levels of antibiotics, and blood collection from peripheral veins; 
physical examinations; food and water deprivation for short periods measured in hours; or standard methods of euthanasia which 
induce rapid unconsciousness, such as anesthetic overdose.) 
 
CATEGORY D:  Research studies in which pain or distress is relieved with appropriate anesthetics, analgesics, or tranquilizer 
drugs (or other means of relieving pain or distress).  Surgery must have adequate anesthesia, and if the animal is recovered after 
surgery and anesthesia, pain control must be instituted. Major surgeries include opening any body cavity, orthopedic procedures, 
etc. 
 
(Examples:  Exposure of blood vessels or implantation of catheters under full anesthesia; behavioral studies on conscious animals 
which involve short-term stressful restraint; noxious stimuli from which escape is possible; and surgical procedures under deep 
anesthesia that may result in only some minor post-operative discomfort or pain.) 
 
CATEGORY E:  Procedures that involve unrelieved pain or distress.  Category E experiments will not normally be approved at 
the University of Nevada, Las Vegas.   The IACUC must have solid scientific justification for withholding agents to alleviate the 
pain or distress before these studies may be approved.  Toxicological or microbial testing or infectious disease research that 
requires that the study continue until animals show clinical signs or death occurs are an example of Category E.  Many such 
procedures may be expressly prohibited by Federal laws, regulation, or policies. Category E procedures will not be approved for 
use in teaching exercises. 
 
(Examples - Severe burn or trauma infliction on anaesthetized animals or without the use of analgesics following awakening from 
anesthesia; application of noxious stimuli (as in shock for behavioral studies), killing by nonapproved methods which may 
involve severe distress or pain before unconsciousness is obtained.)   
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Appendix B 
 
Guidelines for Searches to Alternatives to Animal Use 
 
Introduction 
 
The Animal Welfare Act Regulations, Section 2.31 and USDA (Policy 11 and 12 ) require that a written 
narrative be provided by the Principle Investigator (PI) to determine whether or not alternatives exist to 
procedures which may cause pain or distress in animals used for teaching or research.  
 
Definition of Alternatives 
 
Alternatives refer to methods or approaches which result in refinement of procedures which lessen pain 
and/or distress; reduction in numbers of animals required; or replacement of animals with non-whole-animal 
systems or replacement of one animal species with another, particularly if the substituted species is non-
mammalian or invertebrate. 
 
Animal Welfare Act Regulations 
 
The AWA regulations require the Institutional Animal Care and Use Committee (IACUC) to determine that 
"the principle investigator has considered alternatives to procedures that may cause more than momentary or 
slight pain or distress to the animals and has provided a written narrative description of the methods and 
sources used to determine that alternatives were not available." The PI must provide scientific justification to 
the IACUC if alternatives are available but not used. 
 
Types of Studies Requiring an Alternatives Search 
 
Not all animal use protocols require an alternatives search. Only studies utilizing procedures which result in 
more than momentary or slight pain or distress require a search. Examples of studies that require a search 
include: toxicity and infectious diseases research, tumor induction or transplantation studies, survival and 
non-survival surgical procedures, pain research, in vivo monoclonal or polygonal antibody production 
procedures, fluid and/or food restriction, and prolonged restraint. If you are unsure if your study requires an 
alternative search, either contact one of the institutional veterinarians for advice or just go ahead and do the 
search. If you fail to do a required search for alternatives, approval of your protocol by the IACUC may be 
delayed.  
 
Alternatives Narrative 
 
The minimal written narrative should include: the databases searched or other sources consulted, the date of 
the search and the years covered by the search, and the key words and/or search strategy used by the 
Principal Investigator when considering alternatives or descriptions of other methods and sources used to 
determine that no alternatives were available to the painful or distressful procedure. The narrative should be 
such that the IACUC can readily assess whether the search topics were appropriate and whether the search 
was sufficiently thorough. Reduction, replacement, and refinement (the three R's) must be addressed, not just 
animal replacement. 
 
Database and Web Site Searching 
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In order to perform literature searches that meet regulatory requirements, use key words that would identify 
alternatives to any and all study procedures that may cause more than momentary or slight pain or distress to 
the animals. Problems often arise in choosing keywords and search strategies that will yield the most 
pertinent information. Appropriate search terms or keywords include animal testing alternatives, alternatives, 
tissue culture, cell culture, simulation, in vitro, and model. Keywords should be selected keeping the 3R 
principles in mind. The 3 R's represent reduction in the number of animals used, refinement of techniques 
and procedures that reduce pain and distress, and replacement of animal with non-animal techniques. A list 
of suggested terminology for alternatives from the UC Center for Animal Alternatives website is listed below 
(http://www.vetmed.ucdavis.edu/Animal_Alternatives/main.htm). While this list of terms is not exhaustive, 
you can use it as a model, combining alternatives terms with those specific to your area of research. In your 
database search, combine appropriate text words from this list with text words that are appropriate to the 
particular protocol. Although it is important to include relevant keywords, adding many irrelevant keywords 
that are not likely to identify alternatives with the idea that “more is better” is discouraged and will not 
improve the likelihood that the IACUC will approve your protocol. 
 
alternative  
analges* or sedative*  
anesthe* or anaesthe*  
*animal model*  
animal testing alternative*  
anxiolytic*  
artificial*  
artificial intelligence systems or AI  
assay* or technique* or technic* or method*  
bacteria or protozoa  
behavioral enrichment  
cadaveric model*  
computer aided instruction or CAI  
computer simulation  
computer software or software  
culture and (cell or tissue or organ)  
digital image*  
environmental enrichment  
euthanasia  
fish or cephalopod*  
handling  
housing or facility design or caging  
interactive   
invertebrate*  
mannequin or manikin or mannikin  
mathematical model*  
model*  
plastinat*  
simulat*  
single-cell* organism*  
software  
train* or educat* or teach*  
tranquiliz*  
video*   
virtual and (surg* or reality)  
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vitro and (method or model or technique)  
welfare or pain or stress or distress 
 
Example of a Keyword Search 
 
This example of a keyword search is for a study involving hibernation in ground squirrels.  The keywords to 
be used in a database search for this project include:   
 
hibernation; ischemia AND alternatives; ground squirrel and other models; less invasive AND 
catheterization. 
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